• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

New Tool Lets Users Sign up for Leftover COVID-19 Vaccines

Share:

March 17, 2021

It’s no secret the COVID-19 vaccines are a scare resource. But the combination of temperature constraints and no shows has led to vaccine waste.

A new platform called Dr. B is looking to curb this issue by connecting eligible patients to providers with extra vaccine doses.

“All people have to do is register at HIDRB.com and they are placed on a queue that is ordered based on local government guidelines,” a Dr. B spokesperson wrote in an email to MobiHealthNews. “Providers will let Dr. B know how many extra doses they have, and Dr. B will send a text to the people on the top of the list.”

Patients are matched up with providers in their area, and must respond to Dr. B in order to claim the dose. The company prioritizes vaccine distribution based on the eligibility criteria of the patient’s state or local government.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The site officially launched in January. It’s led by ZocDoc vet Cyrus Massoumi and Dr. Ian Lipkin. The pair joined forces with Vax Standby, which was working on a similar project.

As for the future of the company, a spokesperson said that right now they are focused on COVID-19 and on going live in all 50 states.

WHY IT 4MATTERS

Across the country, states are reporting vaccine waste. In Massachusetts, for instance, news outlet WCVB reports that 1,204 does of the vaccine had gone to waste as of late February.

Dr. B positions itself as a way to cut down on the waste. The company boasts of registering over 1 million people for its queue.

THE LARGER TREND

Increasingly, digital health startups have rolled out tools to help the public find vaccination centers and appointments.

Massoumi’s former company ZocDoc launched a COVID-19 vaccine finder. Additionally, workout-finding app Classpass also rolled out a new feature to help folks find vaccines.

Even tech giants got involved with the effort. In January, Google added a COVID-19 vaccine finder to its search and map platforms. It’s important to note that the bulk of these efforts are focused on helping folks find places to register, rather than find leftover vaccines.

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Fitbit Enters Substance Abuse Recovery with Pretaa PartnershipFitbit Enters Substance Abuse Recovery with Pretaa Partnership
  • Healthcare Staffing Shortages Take Toll on Revenue Cycle Management & Patient EngagementHealthcare Staffing Shortages Take Toll on Revenue Cycle Management & Patient Engagement
  • Discovery Behavioral Health Acquires Casa PalmeraDiscovery Behavioral Health Acquires Casa Palmera
  • FDA Gives Cue Health First EUA for At-home, OTC COVID-19 Molecular TestingFDA Gives Cue Health First EUA for At-home, OTC COVID-19 Molecular Testing
  • Intel & Sheba Partner to Develop AI Solution to Improve Detection of Crohn’s DiseaseIntel & Sheba Partner to Develop AI Solution to Improve Detection of Crohn’s Disease
  • Novartis shares rise as it enters liver disease drug development deal with PfizerNovartis shares rise as it enters liver disease drug development deal with Pfizer
  • HHS Launches Multilingual Vaccine Information ServiceHHS Launches Multilingual Vaccine Information Service
  • Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue(1) Specialty Pharmaceutical CompanyAytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue(1) Specialty Pharmaceutical Company

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications